Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials.
about
Behavioral interventions in patients with an implantable cardioverter defibrillator: lessons learned and where to go from here?Primary prevention of sudden cardiac death: can we afford the cost of cardioverter-defibrillators? Data from the Search-MI Registry-Italian sub-study.Atrial tachyarrhythmias in primary and secondary prevention ICD recipients: clinical and prognostic data.Impact of the multicenter automatic defibrillator implantation trial on clinical practice.Impact of the main implantable cardioverter-defibrillator trials for primary and secondary prevention in Italy: a survey of the national activity during the years 2001-2004.Utility of electrophysiological studies to predict arrhythmic events.Inequity of use of implantable cardioverter defibrillators in England: retrospective analysis.Cost-effectiveness of implantable cardioverter-defibrillators in children with dilated cardiomyopathy.Gaps in Medical and Device Therapy for Patients with Left Ventricular Systolic Dysfunction: The EchoGap Study.Routine implantation of cardioverter/defibrillator devices in patients aged 75 years and older with prior myocardial infarction and left ventricular ejection fraction < 30: antagonist viewpoint.Predicting sudden death in patients with mild to moderate chronic heart failure.Evolution of the implantable cardioverter defibrillator.Psychological functioning and disease-related quality of life in pediatric patients with an implantable cardioverter defibrillator.Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-analysis of randomised controlled trials.Effect of psycho-educational interventions on quality of life in patients with implantable cardioverter defibrillators: a meta-analysis of randomized controlled trials.The role of prophylactic implantable cardioverter defibrillators in heart failure: recent trials usher in a new era of device therapy.Can amiodarone prevent sudden cardiac death in patients with hemodynamically tolerated sustained ventricular tachycardia and coronary artery disease?Prediction of All-Cause Mortality Based on the Direct Measurement of Intrathoracic Impedance.Implantable cardioverter-defibrillators for secondary prevention: is it worth it in the elderly?Revisiting the biomedicalization of aging: clinical trends and ethical challengesClinical effectiveness and cost-effectiveness of implantable cardioverter defibrillators for arrhythmias: a systematic review and economic evaluation.Inequitable distribution of implantable cardioverter defibrillators in Ontario.Arrhythmia risk stratification based on QT interval instability: an intracardiac electrocardiogram study.Psychological intervention following implantation of an implantable defibrillator: a review and future recommendations.Association of psychiatric history and type D personality with symptoms of anxiety, depression, and health status prior to ICD implantation.The Wedensky test predicts malignant ventricular arrhythmias after myocardial infarction.The implantable cardioverter defibrillator: its history, current psychological impact and future.Use of implantable cardioverter defibrillators after out-of-hospital cardiac arrest: a prospective follow-up study.Attrition and adherence in a WEB-Based Distress Management Program for Implantable Cardioverter defibrillator Patients (WEBCARE): randomized controlled trial.Impact of ICD battery longevity on need for device replacements-insights from a Veterans Affairs database.Emotional distress in partners of patients with an implantable cardioverter defibrillator: a systematic review and recommendations for future research.The subcutaneous implantable cardioverter and defibrillator: advantages, limitations and future directions.Posttraumatic stress and anxiety in patients with an implantable cardioverter defibrillator: Trajectories and vulnerability factors.State of the art of ICD programming: Lessons learned and future directions.Implantable cardioverter defibrillator therapy: a single center experience in saudi arabia.Cost-effectiveness of in-home automated external defibrillators for individuals at increased risk of sudden cardiac death.Inappropriate shocks by subcutaneous implantable cardioverter-defibrillator due to T-wave oversensing in hyperkalemia leading to ventricular fibrillation.[Psychological comorbidity and quality of life in patients with an implantable cardioverter/defribrillator (ICD)].[ICD therapy as secondary prevention].Quality of life predicts one-year survival in patients with implantable cardioverter defibrillators.
P2860
Q26823919-F240F9F9-5F46-4EE8-8964-FD99717A96A8Q31085557-74F34290-0518-4AA6-B84A-A09EDED9E366Q31085565-5DD54A11-03C3-4868-93FB-DEC985163340Q33153560-F2B651BB-53AB-43B4-A378-B0782D98F8D3Q33154567-433A5D79-B488-44DD-810B-2193FD4CA07EQ33165958-1FE78CCC-3F6B-4A18-95CC-6D3136706E52Q33869929-6765121E-9D9B-4666-93F0-F9A61916E5C6Q34088903-85A7868E-95ED-4327-B8FA-73F88B22FD85Q34384769-ECA5FBC3-B62B-47AE-B28B-8F6CCA70086CQ35580960-DB2CFE1C-5D42-4DE7-B1D9-DD38F633855BQ35582942-8DC7700E-790A-4924-BDAC-4CA0F71F6F82Q35696656-9FF8900C-8133-42FE-8EBE-248FA74C0BD9Q35851697-B04AA11F-E550-42AB-A44C-E1F9868AAB92Q36103185-3A724B92-8E82-4DF0-98E4-1371C42CA065Q36157174-EFFDCC27-3680-4B6F-8154-2B207A8C04A0Q36203137-8073EDF8-3DFD-4C75-B9D1-DCEE5426701FQ36249082-CDEB1070-5847-4F58-AA08-BF6C36FD3BF1Q36407204-F6AE3CDF-9C5B-40DD-BAC8-71CE3FF1C971Q36416780-80FEF0C1-B3CA-4588-AFBA-19EDC7ACACF6Q36631913-2F9CA728-B314-49F1-9823-4C5E1071A004Q36711669-31404FDD-76DD-49BD-864F-E48CD89F1F0AQ36853736-2607B928-9943-4C09-8FEA-256F2F750676Q36987731-4123A540-0CF0-4AAD-9B00-297EEAB2ABB9Q37028394-0183F375-68BE-4E62-B14F-648AF33D05D3Q37157977-47991AEA-6592-44B3-A371-0DF36DBCE154Q37221844-5839A814-AF9A-4430-80CC-C6DFAD3DA41DQ37357346-518E8773-DAFB-4B10-9E3C-010DEBE45600Q37604180-1410A405-09E5-468D-AE65-5703168332B6Q37653494-83044E77-781A-4BC4-8514-2C7A72E9EC54Q37660527-238B19DC-6243-4D33-A5C3-72CC3139B3A6Q37800139-7DB3D7BC-3E7E-440A-B888-C763004BF1C5Q38574178-D73C532E-4929-49B8-9F8B-E68DC5492980Q38825426-EC78B769-DA74-46F0-BD15-323854C2DBC1Q39151682-985BE68A-C2D4-4318-8754-E1D96399BA24Q41158368-2E252869-89F2-4499-AD22-BA98B3505932Q41466432-4EC50390-3601-4652-99DB-9B85C79502F6Q42200406-2C7CBEF9-76F0-4F67-AA57-2DBED75FC50FQ43019680-E243DDF3-FD60-40E3-88A0-9350A2B827AAQ43053302-CBCDB4C7-3E8B-40B8-8BA2-339E0728273FQ43553910-8AF30A33-5B42-44C2-B6F3-5EE853F66AD7
P2860
Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Implantable cardioverter defib ...... randomized, controlled trials.
@ast
Implantable cardioverter defib ...... randomized, controlled trials.
@en
type
label
Implantable cardioverter defib ...... randomized, controlled trials.
@ast
Implantable cardioverter defib ...... randomized, controlled trials.
@en
prefLabel
Implantable cardioverter defib ...... randomized, controlled trials.
@ast
Implantable cardioverter defib ...... randomized, controlled trials.
@en
P2093
P1476
Implantable cardioverter defib ...... randomized, controlled trials.
@en
P2093
Finlay A McAlister
Justin A Ezekowitz
Paul W Armstrong
P304
P356
10.7326/0003-4819-138-6-200303180-00007
P407
P577
2003-03-01T00:00:00Z